First Human Application of Novel PET Tracer for Prostate Cancer

August 10, 2017

In the featured translational article in the August issue of The Journal of Nuclear Medicine, researchers at the University of Michigan demonstrate the potential of a new PET tracer, Carbon-11 labeled sarcosine (11C-sarcosine), for imaging prostate cancer, and set the stage for its possible use in monitoring other cancers.

The study compared the effectiveness of the new tracer with 11C-choline (already widely used for imaging prostate cancer) in two mouse models and also performed the first PET/CT scan with 11C-sarcosine of a human with prostate cancer.